Loading…
aPKC l/λ a potential target for the therapy of Hh-dependent and Smo-inhibitor-resistant advanced BCC
Basal cell carcinoma (BCC), a skin cancer, is the most common malignancy in white people [1, 2]. Although mor-tality is low as BCC rarely metastasizes, people suffering from BCC are at high risk of developing other malignancies [3]. Given its low metastatic potential, treatment of BCC focuses on loc...
Saved in:
Published in: | 生物化学与生物物理学报:英文版 2013 (7), p.610-611 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Basal cell carcinoma (BCC), a skin cancer, is the most common malignancy in white people [1, 2]. Although mor-tality is low as BCC rarely metastasizes, people suffering from BCC are at high risk of developing other malignancies [3]. Given its low metastatic potential, treatment of BCC focuses on local control, including surgical and non-surgical measures [3, 4]. In the best hands, the 5-year cure rates of ex-cision, curettage and cautery, and cryosurgery are 95% or higher [3]. |
---|---|
ISSN: | 1672-9145 1745-7270 |